http://www.invitrom.org/kirkstall/kirks.html

Medicyte, a leading life sciences company and supplier of  upregulated human primary cells for R&D, has confirmed that it will be a major sponsor of the Conference “Advances in In-Vitro Cell ]]>

Medicyte, a leading life sciences company and supplier of  upregulated human primary cells for R&D, has confirmed that it will be a major sponsor of the Conference “Advances in In-Vitro Cell Culture” to  be held in Utrecht on 22-23 May 2012.

Dr Malcolm Wilkinson, CEO of Kirkstall Ltd said “ I am delighted that Medicyte will be supporting and presenting their work at the conference. They join INVITROM as a major sponsor of the event”  The Medicyte upcyte technology provides an innovative approach to supply of human derived cells for a wide range of R&D work .

Visit   www.medicyte.com/productsservices.html for further details

There will also be exhibition and sponsorship opportunities.

Call for Papers -Utrecht ]]> Call for papers for the conference on “Advances in In-Vitro Cell and Tissue Culture” to be held in Utrecht, The Netherlands on 22-23rd May 2012.

There will also be exhibition and sponsorship opportunities.

Call for Papers -Utrecht 2012 sa

In a recent letter to the Lancet, the leading UK medical journal, several prominent scientists have called for more research into new ways of testing the safety and efficacy of drugs. ]]>

In a recent letter to the Lancet, the leading UK medical journal, several prominent scientists have called for more research into new ways of testing the safety and efficacy of drugs. One of the signatories was Kirkstall’s CEO, Dr J Malcolm Wilkinson.  New methods could also help reduce the dependence on animal testing which, in addition to the ethical arguments against it, has produced misleading results in many cases and could be leading to unnecessary attrition in the drug development pipeline.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61669-3/fulltext

Lancet Article as pdf

The paper is titled Quasi-Vivo® in vitro models as an alternative to use ]]> Dr J Malcolm Wilkinson is to present a paper at Sensor Evolution on 8 November 2011, at ABB Oldends Lane, Stonehouse, GL10 3TA.

The paper is titled Quasi-Vivo® in vitro models as an alternative to use of animals in toxicity

For the full programme go to – Sensor Evolution 2011

Visit Kirkstall in the UK stand #47.

Kirkstall, which specialises in the production of interconnected cell culture systems for ]]> GROWING DYNAMIC FLOW CELL CULTURE specialists Kirkstall Ltd has invested in the establishing its own laboratory and office suite as it expands its operations.

Kirkstall, which specialises in the production of interconnected cell culture systems for physiologically relevant in vitro toxicology screening, has opened new premises at the Sheffield Bioincubator.

The company was formed in 2006 by experienced technologist and entrepreneur Malcolm Wilkinson. The company conducted its first product development from a small lab and office at Sheffield’s Kroto Research Campus.

Initially based on intellectual property from the University of Pisa, Kirkstall has grown steadily from a research & development collaboration and now employs 10 people.

The new laboratory, which measures 680 sq ft, will provide the space and facilities the company needs to carry out further product development whilst offering contract research.

The new premises also include new 500 sq ft offices from which a recently expanded business development team is focussed on a major sales initiative.

Malcolm Wilkinson, Managing Director, said: “The new premises are fantastic and are in the perfect place. Kirkstall is surrounded by world-leading research in an easily accessible location which is important to us and our customers.”

“We started the business with research collaborations and have grown it sensibly by building a highly credible academic client base. We’re now focussed on expanding this with business from new academic and industrial research customers.”

“The secrets of our success are the expertise we offer and international user group we have built for our Quasi Vivo® product.”

Click for further information about Kirkstall Ltd and its Quasi Vivo® product.

Follow further developments at Kirkstall on Twitter, and LinkedIn.